Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Samron Brhane Gebregergish, Mahmoud Hashim, Bart Heeg, Thomas Wilke, Marco Rauland & Ulrike Hostalek. (2020) The cost-effectiveness of metformin in pre-diabetics: a systematic literature review of health economic evaluations. Expert Review of Pharmacoeconomics & Outcomes Research 20:2, pages 207-219.
Read now
Read now
Kristy Iglay, Shannon E. Cartier, Virginia M. Rosen, Victoria Zarotsky, Swapnil N. Rajpathak, Larry Radican & Kaan Tunceli. (2015) Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Current Medical Research and Opinion 31:7, pages 1283-1296.
Read now
Read now
Serge Jabbour & Barry Ziring. (2011) Advantages of Extended-Release Metformin in Patients with Type 2 Diabetes Mellitus. Postgraduate Medicine 123:1, pages 15-23.
Read now
Read now
Abhijit S. Gadkari & Colleen A. McHorney. (2010) Medication nonfulfillment rates and reasons: narrative systematic review. Current Medical Research and Opinion 26:3, pages 683-705.
Read now
Read now
F. Xavier Pi-Sunyer. (2009) The Impact of Weight Gain on Motivation, Compliance, and Metabolic Control in Patients with Type 2 Diabetes Mellitus. Postgraduate Medicine 121:5, pages 94-107.
Read now
Read now
Articles from other publishers (20)
Autumn D. Zuckerman, Josh DeClercq, Nisha B. Shah, Victoria W. Reynolds, Megan E. Peter, Aaron M. Pavlik & Leena Choi. (2022) Primary medication nonadherence calculation method specifications impact resulting rates. Research in Social and Administrative Pharmacy 18:3, pages 2478-2483.
Crossref
Crossref
Emily Lyles, Gilbert Burnham, Lara Chlela, Paul Spiegel, Laura Morlock & Shannon Doocy. (2020) Health service utilization and adherence to medication for hypertension and diabetes among Syrian refugees and affected host communities in Lebanon. Journal of Diabetes & Metabolic Disorders 19:2, pages 1245-1259.
Crossref
Crossref
Judith J. Gout-Zwart, Lisa A. de Jong, Lisanne Saptenno & Maarten J. Postma. (2019) Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands. PharmacoEconomics - Open 4:2, pages 321-330.
Crossref
Crossref
Mary L. Davis-Ajami, Amy Pakyz, Jun Wu & Marianne Baernholdt. (2019) A Payer Perspective of the Costs of Urinary Tract and Skin and Soft Tissue Infections in Adults with Diabetes and the Relationship to Oral Antidiabetic Medication Nonadherence. Journal of Managed Care & Specialty Pharmacy 25:12, pages 1409-1419.
Crossref
Crossref
Andrew McGovern, William Hinton, Silvio Calderara, Neil Munro, Martin Whyte & Simon de Lusignan. (2018) A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study. Diabetes Therapy 9:1, pages 229-242.
Crossref
Crossref
Sarah Thayer, Richard Aguilar, Stephanie Korrer & Wing Chow. (2017) HbA 1c Outcomes in Patients Treated With Canagliflozin Versus Sitagliptin in US Health Plans. Clinical Therapeutics 39:10, pages 2061-2072.
Crossref
Crossref
Matthew Reaney, Colleen A. McHorney, Bradley Curtis, Anna Rydén, Olivier Chassany & Chad Gwaltney. (2017) Using Individual Experiences With Experimental Medications to Predict Medication-Taking Behavior Postauthorization: A DIA Study Endpoints Workstream. Therapeutic Innovation & Regulatory Science 51:4, pages 404-415.
Crossref
Crossref
R. T. Grimes, K. Bennett, H. Hoey, L. Tilson & M. C. Henman. (2016) A retrospective cohort analysis of hypoglycaemic and cardiovascular agent use in young adults in the Irish primary care setting. Irish Journal of Medical Science (1971 -) 186:2, pages 461-470.
Crossref
Crossref
Kristi Reynolds, JaeJin An, Jun Wu, Teresa N. Harrison, Rong Wei, Bruce Stuart, John P. Martin, Catherine S. Wlodarczyk & Swapnil N. Rajpathak. (2016) Treatment discontinuation of oral hypoglycemic agents and healthcare utilization among patients with diabetes. Journal of Diabetes and its Complications 30:8, pages 1443-1451.
Crossref
Crossref
Matthew Reaney, Celeste A. Elash & Leighann Litcher-Kelly. (2016) Patient Reported Outcomes (PROs) used in recent Phase 3 trials for Type 2 Diabetes: A review of concepts assessed by these PROs and factors to consider when choosing a PRO for future trials. Diabetes Research and Clinical Practice 116, pages 54-67.
Crossref
Crossref
R.T. Grimes, K. Bennett, R. Canavan, L. Tilson & M.C. Henman. (2016) The impact of initial antidiabetic agent and use of monitoring agents on prescription costs in newly treated type 2 diabetes: A retrospective cohort analysis. Diabetes Research and Clinical Practice 113, pages 152-159.
Crossref
Crossref
Kam CapocciaPeggy S. OdegardNancy Letassy. (2015) Medication Adherence With Diabetes Medication. The Diabetes Educator 42:1, pages 34-71.
Crossref
Crossref
Colleen A. McHorney. 2016. Handbook of Qualitative Health Research for Evidence-Based Practice. Handbook of Qualitative Health Research for Evidence-Based Practice
473
494
.
Ronan T. Grimes, Kathleen Bennett, Lesley Tilson, Cara Usher, Susan M. Smith & Martin C. Henman. (2015) Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients. British Journal of Clinical Pharmacology 79:6, pages 1000-1009.
Crossref
Crossref
Jan N. Basile. (2013) The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). Journal of Diabetes and its Complications 27:3, pages 280-286.
Crossref
Crossref
L. Guénette, J. Moisan, M.-C. Breton, C. Sirois & J.-P. Grégoire. (2013) Difficulty adhering to antidiabetic treatment: Factors associated with persistence and compliance. Diabetes & Metabolism 39:3, pages 250-257.
Crossref
Crossref
Leo Seman, Sreeraj Macha, Gerhard Nehmiz, Gudrun Simons, Bailuo Ren, Sabine Pinnetti, Hans J. Woerle & Klaus Dugi. (2013) Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose‐Dependent Glucosuria in Healthy Subjects. Clinical Pharmacology in Drug Development 2:2, pages 152-161.
Crossref
Crossref
Ron M. C. Herings & Lars Pedersen. 2012. Pharmacoepidemiology. Pharmacoepidemiology
270
286
.
Fernie Penning-van Beest, Myrthe van Herk-Sukel, Rupert Gale, Jan-Willem Lammers & Ron Herings. (2011) Three-year dispensing patterns with long-acting inhaled drugs in COPD: A database analysis. Respiratory Medicine 105:2, pages 259-265.
Crossref
Crossref
Colleen A. McHorney, C. Victor Spain, Charles M. Alexander & Jeffrey Simmons. (2009) Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: A prospective analysis of data from pharmacy claims. Clinical Therapeutics 31:11, pages 2584-2607.
Crossref
Crossref